Modification of neuropharmacological actions of some drugs by biogenic amine altering agents.
D006916:5-Hydroxytryptophan / Q000494:pharmacology*; D000698:Analgesia; D000818:Animals; D010856:Columbidae; D003864:Depression, Chemical; D005334:Fever / Q000517:prevention & control; D008297:Male; D008750:Methyldopa / Q000494:pharmacology*; D008781:Methyltyrosines / Q000494:pharmacology*; D009020:Morphine; D009526:Nialamide / Q000494:pharmacology*; D010424:Pentobarbital; D010433:Pentylenetetrazole / Q000037:antagonists & inhibitors; D010653:Phenylbutazone; D051381:Rats; D012110:Reserpine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D012640:Seizures / Q000139:chemically induced / Q000517:prevention & control; D012890:Sleep / Q000187:drug effects; D013268:Stimulation, Chemical; D014436:Typhoid-Paratyphoid Vaccines; D014839:Vomiting / Q000139:chemically induced / Q000517:prevention & control
D008781:Methyltyrosines; D014436:Typhoid-Paratyphoid Vaccines; D008750:Methyldopa; D009020:Morphine; D012110:Reserpine; D006916:5-Hydroxytryptophan; D010653:Phenylbutazone; D010424:Pentobarbital; D009526:Nialamide; D010433:Pentylenetetrazole